IOL Chemicals & Pharmaceu Balance Sheet Annual

Trade

BSE: 524164 | NSE: IOLCP | ISIN: INE485C01011 | Sector: Chemical Manufacturing

352.25 +4.10 (1.18%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	7.69	1.39	3.56	17.31
Cash Equivalents	135.20	-	0.00	15.03
Short Term Investments	9.99	21.75	138.09	333.62
Cashand Short Term Investments	152.88	23.14	141.65	365.96
Accounts Receivable- Trade Net	471.23	506.19	473.22	305.01
Total Receivables Net	477.99	552.52	514.05	338.07
Total Inventory	424.84	334.62	415.66	301.48
Other Current Assets Total	64.06	1.90	1.56	11.71
Total Current Assets	1,119.77	920.39	1,080.82	1,022.29
Property/ Plant/ Equipment Total- Net	1,021.39	832.56	662.49	560.42
Intangibles Net	12.61	8.89	3.35	0.21
Long Term Investments	66.28	250.41	204.52	21.39
Other Long Term Assets Total	24.35	7.05	11.12	5.78
Total Assets	2,244.40	2,022.13	1,962.30	1,610.09
Accounts Payable	469.18	314.22	409.29	238.83
Notes Payable/ Short Term Debt	32.76	79.63	42.75	0.00
Current Portof LT Debt/ Capital Leases	0.00	0.18	1.02	0.90
Other Currentliabilities Total	58.06	62.23	60.34	50.82
Total Current Liabilities	560.00	456.26	513.40	290.55
Total Debt	32.76	79.81	43.95	2.73
Deferred Income Tax	66.14	56.36	53.18	53.22
Other Liabilities Total	6.75	1.79	3.26	4.06
Total Liabilities	632.89	514.41	570.02	349.66
Common Stock Total	58.71	58.71	58.71	58.71
Retained Earnings( Accumulated Deficit)	1,552.80	1,230.16	1,114.52	981.48
Total Equity	1,611.51	1,507.72	1,392.28	1,260.43
Total Liabilities Shareholders' Equity	2,244.40	2,022.13	1,962.30	1,610.09
Total Common Shares Outstanding	5.87	5.87	5.87	5.69
Tangible Book Valueper Share Common Eq	272.34	255.31	236.59	221.53
Prepaid Expenses	-	8.21	7.90	5.07
Property/ Plant/ Equipment Total- Gross	-	1,074.20	862.58	723.77
Accumulated Depreciation Total	-	-241.64	-200.09	-163.35
Note Receivable- Long Term	-	2.83	-	-
Long Term Debt	-	0.00	0.00	0.00
Capital Lease Obligations	-	0.00	0.18	1.83
Total Long Term Debt	-	0.00	0.18	1.83
Additional Paid- In Capital	-	225.72	225.72	225.72
Other Equity Total	-	-6.87	-6.67	-5.48
Accrued Expenses	-	-	-	0.00